• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 21 Jul

    Lexaria BioScience Files Application with Senior U.S. Stock Exchange for Uplisting

    KELOWNA, BC / ACCESSWIRE / July 21, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has filed an application with a senior stock exchange in the United States to request an uplisting of the Company's common stock. Lexaria… Read More..

    Share this:
  • 20 Jul

    Soligenix Issues Corporate Update – Highlights Important Catalysts for Second Half of 2020

    PRINCETON, N.J., July 20, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an update letter from its President and Chief Executive Officer, Dr. Christopher… Read More..

    Share this:
  • 16 Jul

    Sono-Tek Sales Grew 22% to $3.43 million in First Quarter Fiscal 2021

    Strong backlog of $3,202,000 Achieved net income of $168,000, up 572% Company expects second quarter revenues to increase over last year MILTON, N.Y., July 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Sono-Tek Corporation (OTCQX: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for… Read More..

    Share this:
« Previous 1 … 176 177 178 179 180 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact